Doseology Sciences Inc. announced the addition of Dr. Olivier Wellman-Labadie to its growing team of mycologists and researchers. Dr. Olivier Wellman-Labadie, Ph.D. has been serving as an Advisor to Doseology and is the Qualified Person in Charge for the Company's Controlled Drugs and Substances Dealer's Licence application. In his role as the QPIC, he will perform the duties required by the Health Canada Controlled Drugs and Substances Dealer's Licence and contribute to the development of psilocybin research and mushroom production. Dr. Wellman-Labadie holds a Doctorate in Molecular Biology from The University of Ottawa, and an MBA with specialization in Pharmaceutical Marketing and Management from Université Laval. He has also obtained a Bachelor of Pharmacy degree from the University of British Columbia and is a registered pharmacist in British Columbia. Since 2007, he has co-authored twelve research papers in the field of molecular biology. Dr. Wellman-Labadie's experience as a registered pharmacist and former Research Associate at the University of Ottawa gives him extensive experience with the efficient operation of laboratory and pharmacological facilities, and his seven years of experience in professional team management will also be greatly beneficial to the Company in his new role. His dedication to his community practice in British Columbia has given him a deep understanding of the challenges faced by diverse populations, including helping patients with mental health and addiction issues. With significant research and laboratory experience, Dr. Wellman-Labadie will directly contribute to Doseology's near-term goal of scaling the production of high-quality mushrooms and psilocybin products for research purposes. He will provide a leadership role in establishing a research facility for the analysis of psilocybin, psilocin, and medicinal mushrooms, and in developing standard operating procedures for the extraction and analysis of psilocybin and psilocin. Furthermore, he will assist with expanding the expert scientific team, liaison with academic research partners, and commencing a psychedelic research program.